Advances in Metastatic Castration Resistant Prostate Cancer (mCRPC) Management
- By Sonali Karhana - Despite recent diagnostic and therapeutic advances, prostate adenocarcinoma is the second most common cancer in the Western male population. One in 7 men over the [...]
Natural Killer Cells are Crucial to Generating Robust Anti-Tumor Immune Response
- By Ramon Valencia, Vice president-Corporate Development & Strategy - The focus of immunotherapy over the last decade has been activating or re-activating T cells. A lesser known, but no [...]